References
Walker MD, Salek SS, Bayer AJ. A review of quality of life in Alzheimer’s disease. Part 1: issues in assessing disease impact. Pharmacoeconomics 1998; 14 (5): 499–530
Salek SS, Walker MD, Bayer AJ. A review of quality of life in Alzheimer’s disease. Part 2: issues in assessing drug effects. Pharmacoeconomics 1998; 14 (6): 613–27
Greer M, Monteban H. A review of quality of life in Alzheimer’s disease. Parts 1 and 2: issues in assessing disease impact and drug effects [letter]. Pharmacoeconomics 1999; 15 (6): 641
Doward LC. The development of the Alzheimer’s carers’ quality of life instrument (ACQLI) [abstract no. 88]. Qual Life Res 1997; 6: Suppl. 7–8: 639
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Salek, S.S., Walker, M.D. & Bayer, A.J. The authors reply. Pharmacoeconomics 16, 417–419 (1999). https://doi.org/10.2165/00019053-199916040-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199916040-00010